Alzheimer’s disease (AD) is a neurodegenerative disorder commonly associated with neuronal metabolic deficits. In this study, we employ an indirect 1H-[13C] MRS approach to investigate changes in glucose metabolism between wild type and transgenic Alzheimer rats. This method can be used to follow the labeling of downstream metabolites after [1-6,13C2] glucose infusion and allows for quantitative measurements of the rate of 13C-label transfer from glucose into glutamate and glutamine in the brain. Preliminary comparison of 13C fractional enrichment time courses suggest that transgenic rats exhibit slower 13C metabolite labeling, indicative of a lowered glucose metabolic rate in AD pathology.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords